EGFR Mutation as a Predictive Factor to Treatment Response of TKI (Tyrosine Kinase Inhibitor) in Non-Small Cell Lung Cancer Stage 4: A Case Report
Non-small cell lung cancer (NSCLC) typically presents in patients at an advanced stage, with a poor prognosis. The development of epidermal growth factor receptor (EGFR) – tyrosine kinase inhibitors (TKIs) and the systematic identification of EGFR mutations heralded the advent of targeted therapy i...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital
2021-03-01
|
Series: | Jurnal Penyakit Dalam Indonesia |
Subjects: | |
Online Access: | http://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/166/266 |